Leaderboard

En | De
No articles selected!     View Cart  
You are here: Urology-Nephrology 10. November 2026
Search
medline.ch
Urology-Nephrology
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Inflammation-Infection
Nephrolithiasis
Renal Failure
Sexuality
Neoplasia/BPH
Others
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 24245  Previews Next
   
   Articles 1 - 20 / 484899  
   
Non-Prostate Cancer-Related Factors That Influence Serum Prostate-Specific Antigen: A Narrative Review of 45 Non-Malignant PSA Modifiers.
Prostate
Stephan C, Jung K, Sutcliffe S, Filella X, Phillips MB, Wolinsky H, Ginsburg K, Keller DK.
PMID: 43002634 [PubMed - as supplied by publisher]


Technical variation and evidence maturity in gender-affirming peritoneal vaginoplasty: a systematic review.
J Sex Med
Vallinga MS, Roijer PJ, Jorna MMF, de Vries R, van der Sluis WB, Tuynman JB, Mullender MG, Bouman MB.
PMID: 43002587 [PubMed - indexed for MEDLINE]


18F-FAPI PET/CT and Cardiac Magnetic Resonance for Cardiac Fibrotic Process in End-stage Renal Disease: A Pilot Study.
Clin Nucl Med
Wu T, Luo C, Yang G, Zhang N, Li B, Zhou R, Zhang M, Zhu Z, Ma S, Dong W, Fu X, Wang X, Nie P.
PMID: 43002574 [PubMed - as supplied by publisher]


PARP inhibitors in metastatic prostate cancer: current evidence and future directions.
Clin Adv Hematol Oncol
McKendry K, Maurice-Dror C, Chi KN.
PMID: 43002478 [PubMed - indexed for MEDLINE]


Polygenic Risk Scores for Kidney Function Decline in Japanese Population-Based Cohorts: A Validation Study.
Kidney360
Oshima M, Toyama T, Hara A, Asayama A, Yamaguchi T, Tajima A, Tsujiguchi H, Ozawa M, Sato T, Hosomichi K, Kannon T, Takeshita Y, Takamura T, Sakai N, Shimizu M, Nakamura H, Wada T, Iwata Y.
PMID: 43002477 [PubMed - as supplied by publisher]


Development and Validation of a Nomogram Predictive Model for Postoperative Complications After Laparoscopic Partial Nephrectomy by Combining RENAL Score, MAP Score and Preoperative Baseline Characteristics.
Urol Int
Li Y, Cao J, Li J, Jiang C, Tian G, Feng Y, Yang H, Xu Y, Chen Y, Nie L, Zhao R.
PMID: 43002435 [PubMed - as supplied by publisher]


Knowledge, attitudes and practices of Swiss reproductive health and paediatrics professionals regarding female genital mutilation/cutting: a cross-sectional study.
Swiss Med Wkly
Bazzoun Y, Marea C, Abdulcadir J.
PMID: 43002389 [PubMed - indexed for MEDLINE]


Expanding transplant access via robotics: a multi-center American experience with 671 robotic kidney transplants.
J Robot Surg
Abreu P, Kadri H, Alaniz J, Kiani A, Godfrey C, Vachharajani N, Schold JD, Pshak T, Khan AS, Spaggiari M, ART Consortium.
PMID: 43002268 [PubMed - indexed for MEDLINE]


PODIUM renal dysfunction criteria identify children with higher severity of illness than KDIGO acute kidney injury criteria in an observational cohort study.
Pediatr Nephrol
Dixon CG, Kirchner V, Yehya N, Fitzgerald JC.
PMID: 43002226 [PubMed - as supplied by publisher]


Neonatal kidney injury: diagnosis, management, and long-term kidney health - the perspective of the European Neonatal Nephrology Working Group.
Pediatr Nephrol
Hoogenboom LA, Hundscheid T, Snauwaert E, Vidal E, Ng NSL, Ognean ML, Habbig S, Baeta Babtista R, Dufek-Kamperis S, Raffaeli G, Schreuder MF, Athiraman NK, Molloy E, van de Walle J, Stabouli S, Allegaert K, Raaijmakers A, ESPN Working Group and ESPR Special Interest Group neonatal nephrology.
PMID: 43002221 [PubMed - as supplied by publisher]


A new antioxidant nutraceutical compound is able to reduce the level of prostate pro-inflammatory mediators: results from a phase III, placebo controlled trial.
Arch Ital Urol Androl
Ceccato T, Botti S, Mattevi D, Gallelli L, Mazzoli S, Rizzo M, Liguori G, Palumbo F, Palmieri A, Zucchi A, Bjerklund Johansen T, Cai T.
PMID: 43001840 [PubMed - as supplied by publisher]


Does incremental inspiratory muscle training provide additional benefits over minimal‑load training for respiratory muscle strength, diaphragm thickness, and diaphragmatic excursion in patients with pre‑dialysis chronic kidney disease? A randomized clinical trial.
Physiother Theory Pract
Moraes de Macêdo T, Soares de Oliveira M, Xavier Nunes DT, Marinho Cunha BL, de Melo Marinho PÉ.
PMID: 43001776 [PubMed - as supplied by publisher]


Efficacy, Safety, and Biomarker Analysis of Toripalimab Monoclonal Antibody Combined With Gemcitabine and Cisplatin Chemotherapy as Neoadjuvant Treatment in Muscle-Invasive Bladder Cancer: A Phase II Clinical Trial: Erratum.
J Urol
Zhang S, Li T, Li D, Yin Y, Zhu W, Jiang N, Zhang S, Yang R, Guo H.
PMID: 43001677 [PubMed - in process]


The Journal of Urology(®) Home Study Course 2026 Volume 216.
J Urol

PMID: 43001675 [PubMed - in process]


Internet Access, Health-Related Internet Use, and Pelvic Floor Muscle Exercise Adherence Among Prostate Cancer Patients With Urinary Incontinence After Radical Prostatectomy: A Cross-Sectional Study.
Cancer Nurs
Huang H, He Y, Qu Y, Zhang L, Zhao Y, Gu C, Weng X, Li S, Gong J.
PMID: 43001635 [PubMed - as supplied by publisher]


The relevance of genetic disease in kidney transplantation.
Curr Opin Organ Transplant
Arnaldi M, Connaughton DM.
PMID: 43001516 [PubMed - indexed for MEDLINE]


Longitudinal changes in proteinuria and kidney function during standard-dose Nefecon treatment in IgA nephropathy: A real-world cohort study.
Clin Nephrol
Yin Y, Lin H, Xiao Q, Li S, Xu L, Ma J, Liu S, Tao Y.
PMID: 43001348 [PubMed - as supplied by publisher]


Adiposity and glycemic patterns among adults meeting measured cardiovascular-kidney-metabolic stage 1 criteria: a multicohort study.
Int J Cardiol Heart Vasc
Huang B, Xu H.
PMID: 43001303 [PubMed]


Optimized pharmacotherapeutic management of immune checkpoint inhibitor treatment in metastatic clear-cell renal cell carcinoma.
Expert Opin Pharmacother
Sridharan K, Roviello G, Massari F, Sivaramakrishnan G, Calandrelli C, Santoni M.
PMID: 43000686 [PubMed - as supplied by publisher]


Clinical and translational profiling of oncotherad (MRB-CFI-1) nanoimmunotherapy identifies HER-2/SERBP1-associated recurrence and HABP4/IFN-γ-associated disease control in pT1 non-muscle-invasive bladder cancer after BCG failure.
J Cancer Res Clin Oncol
Gonçalves JM, de Arruda Camargo GC, de Oliveira G, Caria PHF, da Silva Santos A, de Castro Roston JR, de Moraes Lacerda T, de Jesus MB, de Freitas LLL, Bottene MC, Lestingi JFP, Kobarg J, Durán N, Alonso JCC, Fávaro WJ.
PMID: 43000577 [PubMed - indexed for MEDLINE]


   
   Articles 1 - 20 / 484899    Page 1 of 24245  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1